论文部分内容阅读
目的:规范药物经济学评价方法,提高国内评价研究的系统性及科学性。方法:采用文献研究法,结合自身开展研究项目经验,探讨国内药物经济学应用研究中存在的问题,提出促进国内药物经济学研究及应用的对策。结果与结论:国内药物经济学研究和应用尚存在研究角度选择不清晰、成本测算项目不明确、对照药物或治疗方案选取欠合理、药物经济学产出指标缺乏标准、中药的药物经济学评价缺乏评价指标等问题。应明确研究角度、规范成本测算、建立完善的健康产出指标标准、加强药物经济学评价技术要点制订,使药物经济学评价更科学、更规范、更具可比性。
Objective: To standardize the evaluation method of pharmacoeconomics and to improve the systematic and scientific research of domestic evaluation. Methods: Using the literature research method, combined with its own experience in carrying out research projects to explore the problems in the application of domestic pharmacoeconomics, put forward countermeasures to promote the domestic pharmaceutical economics research and application. RESULTS AND CONCLUSION: The study and application of domestic pharmacoeconomics still have unclear choices in terms of research perspective, unclear items of cost estimation, inadequate selection of control drugs or treatment options, lack of standards in indicators of pharmaceutical economics, lack of evaluation of pharmacoeconomics in traditional Chinese medicine Evaluation index and other issues. It is necessary to clarify the research perspective, standardize the cost estimates, establish and improve the standard of health output indicators, strengthen the technical evaluation of drug economics, and make the evaluation of pharmaceutical economics more scientific, more standardized and more comparable.